Eidos治疗(EIDX)

122.21 0.00 0.0%

今开:0.0昨收:122.21
最高:0.0 最低:0.0
涨停价:0.0跌停价:0.0
总市值:4.74931561E9

Eidos治疗的热门评论

chuminhua2020-12-15 11:33

12/14,据彭博社援引匿名消息来源的报道称,Eidos Therapeutics于11月收到葛兰素史克(GlaxoSmithKline)的收购要约。Eidos已经同意BridgeBio Pharma的收购要约,该公司在最近的一份文件中披露,“大型国际制药公司”在11月下旬以每股120美元的全现金,无约束力的出价竞标了Eidos。
据彭博社报...查看全文

Eidos治疗(EIDX)2020-03-31 04:30

$Eidos治疗(EIDX)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000899243-20-009640 Size: 10 KB 网页链接查看全文

Eidos治疗(EIDX)2020-03-24 18:15

$Eidos治疗(EIDX)$ 8-K Current report, item 8.01 Accession Number: 0001193125-20-083086 Act: 34 Size: 32 KB 网页链接查看全文

Eidos治疗(EIDX)2020-03-05 05:15

$Eidos治疗(EIDX)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000899243-20-006944 Size: 10 KB 网页链接查看全文

Eidos治疗(EIDX)2020-02-27 05:40

$Eidos治疗(EIDX)$ 8-K Current report, items 2.02 and 9.01 Accession Number: 0001564590-20-006810 Act: 34 Size: 439 KB 网页链接查看全文

Eidos治疗(EIDX)2020-03-05 05:15

$Eidos治疗(EIDX)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000899243-20-006941 Size: 5 KB 网页链接查看全文

Eidos治疗(EIDX)2020-02-27 05:50

$Eidos治疗(EIDX)$ 10-K Annual report [Section 13 and 15(d), not S-K Item 405] Accession Number: 0001564590-20-006823 Act: 34 Size: 12 MB 网页链接查看全文

Eidos治疗(EIDX)2020-02-19 19:15

$Eidos治疗(EIDX)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000899243-20-005000 Size: 7 KB 网页链接查看全文

Eidos治疗(EIDX)2020-02-06 05:15

$Eidos治疗(EIDX)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000899243-20-003247 Size: 15 KB 网页链接查看全文

1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20

Eidos治疗的最新评论

Eidos治疗(EIDX)2019-11-23 10:10

$Eidos治疗(EIDX)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000899243-19-028029 Size: 6 KB 网页链接查看全文

Eidos治疗(EIDX)2019-11-23 10:10

$Eidos治疗(EIDX)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000899243-19-028028 Size: 5 KB 网页链接查看全文

Eidos治疗(EIDX)2019-11-20 05:15

$Eidos治疗(EIDX)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000899243-19-027574 Size: 12 KB 网页链接查看全文

Eidos治疗(EIDX)2019-11-18 21:10

$Eidos治疗(EIDX)$ 8-K Current report, items 1.01, 2.03, 8.01, and 9.01 Accession Number: 0001193125-19-293984 Act: 34 Size: 263 KB 网页链接查看全文

Eidos治疗(EIDX)2019-11-02 02:00

$Eidos治疗(EIDX)$ 8-K - Current report Filed: 2019-10-31 AccNo: 0001564590-19-039164 Size: 449 KBItem 2.02: Results of Operations and Financial ConditionItem 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory...查看全文

Eidos治疗(EIDX)2019-11-02 02:00

$Eidos治疗(EIDX)$ 10-Q - Quarterly report [Sections 13 or 15(d)] Filed: 2019-10-31 AccNo: 0001564590-19-039169 Size: 9 MB 网页链接查看全文

chuminhua2019-10-20 23:11

10/14,BridgeBio Pharma$BridgeBio Pharma(BBIO)$ 放弃收购其子公司Eidos Therapeutics$Eidos治疗(EIDX)$ 。2017年BridgeBio创办了Eidos以开发AG10,这是用于转甲状腺素蛋白淀粉样变性的药物。第二年,Eidos上市,BridgeBio拥有该公司66%的股份。BridgeBio原计划今年早些时候收购该公司剩余的34%...查看全文

Eidos治疗(EIDX)2019-10-15 21:50

$Eidos治疗(EIDX)$ SC 13D/A [Amend] - General statement of acquisition of beneficial ownership Filed: 2019-10-15 AccNo: 0001193125-19-267356 Size: 46 KB 网页链接查看全文

Eidos治疗(EIDX)2019-09-14 09:50

$Eidos治疗(EIDX)$ 8-K - Current report Filed: 2019-09-13 AccNo: 0001193125-19-244853 Size: 31 KBItem 8.01: Other EventsItem 9.01: Financial Statements and Exhibits 网页链接查看全文

Eidos治疗(EIDX)2019-09-13 01:40

$Eidos治疗(EIDX)$ 8-K - Current report Filed: 2019-09-11 AccNo: 0001193125-19-243001 Size: 48 KBItem 1.01: Entry into a Material Definitive AgreementItem 3.02: Unregistered Sales of Equity SecuritiesItem 7.01: Regulation FD DisclosureItem 9.01: Financial Statements and Exhibi...查看全文

1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20

Eidos治疗的公告

$Eidos治疗(EIDX)$ SC 13D/A [Amend] General statement of acquisition of beneficial ownership Accession Number: 0001193125-21-017733 Size: 29 KB 网页链接

$Eidos治疗(EIDX)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000899243-21-003286 Size: 7 KB 网页链接

$Eidos治疗(EIDX)$ POS AM Post-Effective amendments for registration statement Accession Number: 0001193125-21-017696 Act: 33 Size: 22 KB 网页链接

$Eidos治疗(EIDX)$ S-8 POS Securities to be offered to employees in employee benefit plans, post-effective amendments Accession Number: 0001193125-21-017697 Act: 33 Size: 23 KB 网页链接

$Eidos治疗(EIDX)$ S-8 POS Securities to be offered to employees in employee benefit plans, post-effective amendments Accession Number: 0001193125-21-017698 Act: 33 Size: 23 KB 网页链接

$Eidos治疗(EIDX)$ S-8 POS Securities to be offered to employees in employee benefit plans, post-effective amendments Accession Number: 0001193125-21-017699 Act: 33 Size: 23 KB 网页链接

$Eidos治疗(EIDX)$ SC 13D/A [Amend] General statement of acquisition of beneficial ownership Accession Number: 0001193125-21-017128 Act: 34 Size: 33 KB 网页链接

$Eidos治疗(EIDX)$ 8-K Current report, items 1.01, 2.01, 2.03, 3.01, 3.03, 5.01, 5.02, 5.03, and 9.01 Accession Number: 0001193125-21-017109 Act: 34 Size: 381 KB 网页链接

$Eidos治疗(EIDX)$ 25-NSE Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securities Accession Number: 0001354457-21-000105 Act: 34 Size: 2 KB 网页链接

$Eidos治疗(EIDX)$ 8-K Current report, items 5.07, 8.01, and 9.01 Accession Number: 0001193125-21-012447 Act: 34 Size: 208 KB 网页链接

1 2 3 4 5 6 7 8 9 10 11 12 13 14 15